Providing independent clinical excellence since 2005
Continuous glucose monitors reveal how differently individuals respond to carbohydrates. We classify these responses using Glucotype, which reflects innate carbohydrate tolerance, and Current Glucose Profile (CGP), which shows a person’s present metabolic state. Combined with visceral fat grading, this system helps identify metabolic risk and guide personalised dietary or medical interventions.
Prediabetes should be viewed as an active cardiometabolic disease stage rather than a passive risk marker. Cardiovascular injury begins before overt diabetes, creating a critical window for intervention. Lifestyle therapy remains fundamental, while agents such as metformin, GLP-1 receptor agonists, dual incretin therapies, and SGLT2 inhibitors may help modify long-term cardiovascular risk.
Recent scientific discoveries have aligned much like planets, leading to an inescapable conclusion among many physicians that glucose metabolism may be even more important than LDL cholesterol in the genesis of many modern diseases.
Continuous glucose monitoring offers a valuable tool for anyone concerned with their long-term health, especially those with a family history of diabetes or other cardiovascular risk factors. Whether through self-monitoring or professional analysis such as our metabolic health assessment, CGMs can provide actionable insights that help individuals manage their glucose levels more effectively, ultimately contributing to a healthier, longer life. By understanding and managing your glucotype, optimising your diet and exercise, and taking steps to prevent prediabetes and diabetes, you can potentially avoid serious health conditions in the future.
This blog explores how individuals can conduct their own experiments to maintain a steady blood glucose and avoid potentially unhealthy glucose spikes above 7.8 mmol/L (140 mg/dL).
There is a wealth of evidence linking pre-diabetes, raised HbA1c, and full-blown type 2 diabetes to increasing cardiovascular risk. Lesser degrees of a pre diabetic metabolism could therefore have an important role in causing long-term atherosclerosis.
Continuous glucose monitors are transforming diabetes care, but their insights may extend far beyond diabetic patients. Evidence suggests that post-meal glucose spikes and glucose variability may influence cardiovascular health. While definitive trials are still needed, CGMs offer a practical tool to help patients understand metabolic responses and adopt healthier dietary and lifestyle habits.
Written by Dr Edward Leatham, Consultant Cardiologist: Our metabolic health screen incorporates data processing to provide feedback to the patient on their GV status, using both graphical and numerical stats.
When blood sugar levels are consistently high, causing prediabetes and diabetes, the risk of conditions such as heart disease and type 2 diabetes increase in the long-term. It is easy to understand why the phenomenon of glucose spiking, where blood sugar levels surge and then fall back into the normal range after a meal, is also widely considered to be harmful.